期刊文献+

非小细胞肺癌病人源性NOD/SCID小鼠和BALB/c裸鼠移植瘤模型的建立及比较 被引量:3

Comparison of patientderived non-small cell lung cancer xenegrafts models in NOD/SCID and nude mice
下载PDF
导出
摘要 目的:构建人非小细胞肺癌的NOD/SCID小鼠和BALB/c裸鼠移植瘤模型,并探讨移植瘤成瘤性与小鼠品系间的关系,为后续建立优良的动物模型奠定基础。方法:取手术切除获得的23例非小细胞肺癌组织,1 h内移植于NOD/SCID小鼠或BALB/c裸鼠皮下,观察移植瘤成瘤情况,测量移植瘤体积,绘制生长曲线图,计算成瘤率、成瘤潜伏时间和成瘤时间,分析并比较移植成瘤组和未成瘤组所对应患者的相关临床病理指标,并取移植成瘤组和所对应患者的组织标本进行病理学分析。结果:NOD/SCID小鼠皮下移植瘤模型成瘤率(55.6%),BALB/c裸鼠皮下移植瘤模型(20%),两者间差异无统计学意义(P>0.05),但前者的成瘤潜伏时间和成瘤时间均短于后者(P<0.05)。患者相关临床病理指标中鳞癌、TNM分期和淋巴结转移情况与移植瘤成瘤建模无明显相关(P=0.109、0.153、0.077),NOD/SCID小鼠和BALB/c裸鼠皮下移植瘤模型均能保持病人肺癌肿瘤组织的形态学特征。结论:成功构建了NOD/SCID小鼠和BALB/c裸鼠皮下移植瘤模型,NOD/SCID小鼠更适宜用于肺癌病人源性皮下移植瘤模型的建立,非小细胞肺癌移植瘤模型的建立为进行体外抗肿瘤药物的筛选提供了良好的研究工具。 OBJECTIVE:To establish patient-derived non-small cell lung cancer xenegraft models in NOD/SCID or nude mice,and to compare the tumor-forming rates between these mice.METHODS:Non-small cell lung cancer tissues were collected from 23 patients who underwent surgical resection at the Department of Thoracic Surgery of Beijing Chest Hospital from July 2016 to December 2016.Non-small cell lung cancer tissues were subcutaneously implanted into NOD/SCID mice or BALB/c nude mice within 1 hour after surgical resection.Growth processes of the xenotransplanted tumors were observed,the tumor volumes were measured and the growth curves of the xenotransplanted tumors were plotted.The tumor-forming rates,the tumor latent time and the tumor formatting time were calculated.Then,comparison was made on morphology of patient-derived tumor xenegraft tissue and corresponding primary tumor tissue,and the related patients clinical pathological index of two groups,that could form xenegraft tumor group and couldn't form xenergraft tumor group.RESULTS:Xenegrafts were successfully established(55.6%)in NOD/SCID and(20%)nude mice.The tumor-forming rates of NOD/SCID mice models were higher than the nude mice models,and the tumor latent time(37 d,60 d,P=0.002)and the tumor formatting time(79 d,110 d,P=0.002)had significant differences.Tumor factors might associate with engraftment included squamous histology,TNM stage and the lymph node metastasis.Both mice models could keep the morphology of patient-derived tumor xenegraft tissues.CONCLUSION:The xenotransplantation models of patient-derived non-small cell lung cancer in both NOD/SCID mice and nude mice were successfully established.In comparison with the BALB/c nude mice model,the tumor-forming rates of the NOD/SCID mice model was higher,the tumor latent times and the tumor formatting times were shorter,suggesting that the NOD/SICD mice model was more suitable for the establishment of patient-derived NSCLC xenegraft model.
作者 吴健彬 江妹 王玥 许晶 岳文涛 王子彤 WU Jianbin;JIANG Mei;WANG Yue;XU Jing;YUE Wentao;WANG Zitong(Department of Thoracic Surgery,Beijing Chest Hospital,Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute,Beijing 101149;Department of Cellular and Molecular Biology,Beijing Chest Hospital,Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute,Beijing 101149;Central Laboratory,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,China)
出处 《癌变.畸变.突变》 CAS CSCD 2018年第2期114-119,共6页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 北京市自然科学基金(7174289)
关键词 非小细胞肺癌 模型 NOD/SCID小鼠 BALB/C裸鼠 NSCLC model NOD/SCID mice BALB/c nude mice
  • 相关文献

参考文献2

二级参考文献24

  • 1徐冰,姚明,闫明霞,张杰,刘蕾,顾为望.人肝癌NOD-SCID小鼠原位移植模型的建立及其生物学特性的研究[J].肿瘤,2006,26(11):975-978. 被引量:6
  • 2王梅梅,凌斌,赵卫东,周颖,陈峥峥,姚凤球,石永云,高婷,许恬怡,冯定庆,沈国栋,陈敏,朱园园.人子宫内膜癌SCID鼠皮下移植瘤模型的建立及其生物学特性初探[J].安徽医学,2007,28(1):5-7. 被引量:1
  • 3Perez-Soler R, Kemp B, Wu Q P, et al. Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice. Clin Cancer Res, 2000, 6(12): 4932-4938.
  • 4Fichtner I, KolffJ, Soong K, et al. Establishment of patient-derived non- small cell lung cancer xenografts as models for the identification of predictive biomarkers. Clin Cancer Res, 2008, 14(20): 64S6-6468.
  • 5Bankert RB, Egilmez NK, Hess SD. Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends Immunol, 2001, 22(7): 386-393.
  • 6Bankert RB, Hess SD, Egilmez NK. SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions. Front Biosci, 2002, 7: c44-c62.
  • 7Dustin ML, de Fougerolles AR. Reprogramming T cells: the role of extracellular matrix in coordination of T ceU activation and migration. Curr Opin Immunol, 2001, 13(3): 286-290.
  • 8Ibe S, Qin Z, Schuler T, et al. Tumor rejection by disturbing tumor stroma cell interactions.J Exp Med, 2001, 194(11): 1549-1559.
  • 9McCawley LJ, Matrisian LM. Tumor progression: defining the soil round the tumor seed. Curt Biol, 2001, 11(1): R25-R27.
  • 10Tlsty TD. Stromal cells can contribute oncogenic signals. Semin Cancer Biol, 2001, 11(2): 97-104.

共引文献18

同被引文献30

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部